Pfizer Raises Sales Forecast for COVID-19 Biologic to $33.5 Billion in 2021
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of this year raising the company’s 2021 sales forecast for the two-dose vaccine to $33.5 billion…
CONTINUE READINGExisting Drugs Hold Promise for Treatment of COVID-19
Story Highlights A group of Israeli researchers have studied close to 3,000 approved drugs to see if any could be…
Johnson & Johnson Recalls Carcinogen Containing Sunscreen Products
On July 14, 2021, Johnson and Johnson Consumer, Inc. voluntarily recalled all batches of five NEUTROGENA and AVEENO aerosol sunscreen…
75 Percent COVID-19 Vaccination Rate Among U.S. Hospital Workers
An analysis conducted by WebMD and Medscape Medical News from data collected by the U.S. Department of Health and Human…
Former FDA Chief Stephen Hahn Joins Venture Capital Firm Behind Moderna COVID Vaccine
Stephen Hahn, MD, who served as commissioner of the U.S. Food and Drug Administration (FDA) from Dec. 17, 2019 through…
40 Percent of U.S. Marines Opting Out of COVID-19 Vaccination
Story Highlights Among U.S. military forces, the rate of refusal for the experimental COVID-19 vaccines is reportedly at about 33…
Poll: Half of Correctional Officers Do Not Want COVID-19 Vaccine
When a correctional officer took a poll of his co-workers on a private Facebook group asking whether they would get…